HYPERTENSION AS A PREDICTOR OF DIABETIC RETINOPATHY AT A TERTIARY CARE HOSPITAL by ZAINAB, ALINA et al.
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.47, 2018 
 
30 
HYPERTENSION AS A PREDICTOR OF DIABETIC 
RETINOPATHY AT A TERTIARY CARE HOSPITAL 
 
DR. ALINA ZAINAB, MBBS 
Nishtar Hospital, Multan, Pakistan. 
 
DR. NOOR UL AIN, MBBS 
Nishtar Hospital, Multan, Pakistan. 
 
DR. AMNA MUNIR, MBBS 
Nishtar Hospital, Multan, Pakistan. 
ABSTRACT;  
Background; In the year 2000, there were around 171 million people with diabetes globally, and by 2030, it is 
estimated that this number would increase to 366 million. These microvascular complications are linked to the 
duration of diabetes mellitus, poor glycemic control and systolic hypertension. Objective: To determine the 
frequency diabetic retinopathy (DR) in diabetic patients with hypertension. Subjects and Methods; A total of 
365 diabetic patients having hypertension were included in our study using non – probability consecutive 
sampling technique. These patients were screened for diabetic retinopathy. All the information was recorded in 
the proforma and data was analyzed by using SPSS version 22. Results; Of these 365 study cases, 226 (61.9 %) 
were male patients while 139 (38.1 %) were female patients. Mean age of our study cases was 50.92 ± 5.77 years 
(with minimum age of our study cases was 40 years while maximum age was 60 years). Of these 365 study cases, 
127 (34.8 %) belonged to rural areas and 238 (65.2 %) belonged to urban areas. Monthly family income up to Rs. 
25000 was noted in 188 (51.5%) and 177 (48.5%) had monthly family income rupees more than 25000. History 
of smoking was present in 89 (24.4%) of our study cases.  
Mean body mass index was 26.32 ± 2.45 kg/m
2 
and obesity was present in 112 (30.7 %) of our study cases. 
Mean disease duration was 12.35 ± 7.52 years and 239 (65.5%) had duration of illness more than 5 years. Of 
these 365 study cases, 238 (65.2 %) were illiterate and 127 (34.8 %) were literate. Controlled diabetes was noted 
in 75 (20.5%) and 75 (20.5%) were taking proper treatment. Diabetic retinopathy was 151 (41.4%) of our study 
cases. Conclusion; Very high frequency of diabetic retinopathy was noted in patients with diabetes and 
hypertension in our study. Diabetic retinopathy was significantly associated with residential status, increasing 
age, monthly family income, smoking, treatment status, disease duration and obesity. Diabetic retinopathy was 
not associated with control of diabetes and hypertension. All clinicians treating such patients must educate their 
patients regarding regular eye check up to decrease disease morbidity.   
Keywords; Diabetic retinopathy, hypertension, frequency.  
 
INTRODUCTION; 
Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin 
secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term damage, 
dysfunction, and failure of different organs, especially eyes; kidneys, nerves, heart, and blood vessels.1There are 
three main types of diabetes mellitus (DM): Type I, Type II and gestational diabetes.
2 
 The multisystem 
complications of diabetes such as retinopathy, nephropathy, neuropathy and cardiovascular diseases are 
considered important, impinging on public health.
3
 Diabetic nephropathy (DN) and diabetic retinopathy (DR) 
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are arguably the two most dreaded complications of diabetes. Together they contribute to serious morbidity and 
mortality. As they progress to end-stage renal disease (ESRD) and blindness, they impose enormous medical, 
economic, and social costs on both the patient and the health care system. Because nephropathy and retinopathy 
are frequently linked in patients.
4  
Diabetic retinopathy, which is a common complication in diabetes, is 
characterized by retinal vascular leakage, inflammation and abnormal neovascularization 
5, 6
. DR is recognized 
as a leading cause of blindness and visual impairment in working-age adults in developed and developing 
countries. The World Health Organization (WHO) lists DR as a priority disease in their “VISION 2020” 
program initiative for the global elimination of avoidable blindness. Potential risk factors of DR include age, 
duration of diabetes, glycemic level, blood pressure, pregnancy and nephropathy. 
7-9
 However, risk reduction for 
DR with glucose and BP control in diabetic patients is limited. Diabetic retinopathy is a common complication 
of diabetes and a leading cause of visual impairment and blindness. Research has established the importance of 
blood glucose control to prevent development and progression of the ocular complications of diabetes. 
Simultaneous blood pressure control has been advocated for the same purpose, but findings reported from 
individual studies have supported varying conclusions regarding the ocular benefit of interventions on blood 
pressure 10, 11. 
A large number of studies have evaluated the effect of elevated blood pressure on the development and 
progression of diabetic retinopathy and conversely, the effect of blood pressure reduction on preventing such 
progression. Among the more, notable was the UKPDS, which evaluated blood pressure reduction using either 
an angiotensin-converting enzyme inhibitor or a beta-adrenergic blocker, in conjunction with other drugs as 
needed to reduce blood pressure, by comparison with controls, who received no antihypertensive medication, in 
type 2 diabetics. Most of these patients were hypertensive (systolic blood pressure more than 150 mm Hg) at the 
outset of the study. Reduction of blood pressure by either drug prevented retinopathy progression. Other studies, 
some with diabetic patients who were normotensive at the outset, showed little or no effect of blood pressure 
reduction. The Action to Control Cardiovascular Risk in Diabetes (ACCORD)-Eye Study, for example, showed 
that blood pressure reduction in type 2 diabetic patients had no effect on the development or progression of 
diabetic retinopathy. 
12 
A study from Jordan conducted by Al-Amer et al 
13
 reported 38.7 % diabetic retinopathy 
in diabetic patients having hypertension.  
Diabetic retinopathy leads to significant morbidity and affects functional status of the main work force of the 
society. Previous studies have reported that control of diabetes and blood pressure can lead to improvement in 
visual outcomes.  
 
 
MATERIALS AND METHODS: 
A total of 365 patients with Type 2 diabetes mellitus and hypertension aged up to 60 years of either sex were 
enrolled in our descriptive cross-sectional study.  
Patients underwent any form of retinal surgery / laser therapy, on ACE-inhibitors or ARBs, Kidney disease 
(Nephrotic syndrome, Nephritic Syndrome) not related with diabetes, patient having cataract were excluded 
from our study.  
A total of 365 type 2 diabetic hypertensive patients presenting in Diabetes OPD fulfilling the inclusion criteria 
were selected from Diabetes outdoor clinic of Nishtar Hospital Multan. Once registered, all patients had 
undergone retinal imaging using Non Mydriatic Fundus Camera (NIDEK
®
 Model # AFC-330). All retinal 
images were interpreted and reported by consultant ophthalmologist from department of ophthalmology Nishtar 
Hospital Multan. Collected Data was entered into SPSS version 22 and was analyzed through its statistical 
package. Descriptive statistics was used to analyze the data. Mean ±S.D. was calculated for age of the patients, 
height, weight and BMI. Frequencies and percentages were calculated for qualitative variables like gender, DR, 
obesity, history of smoking, regular eye check up, level of education, residential status and monthly family 
income.  
    RESULTS; 
Our study comprised of a total of 365 patients meeting inclusion criteria of our study. Of these 365 study cases, 
226 (61.9 %) were male patients while 139 (38.1 %) were female patients. Mean age of our study cases was 
50.92 ± 5.77 years (with minimum age of our study cases was 40 years while maximum age was 60 years). 
Mean age of the male patients was noted to be 51.49 ± 5.20 years while that female patients was 50.00 ± 6.38 
years (p=0.016). Our study results have indicated that majority of our study cases i.e. 190 (52.1 %) were aged 
more than 50 years. Of these 365 study cases, 127 (34.8 %) belonged to rural areas and 238 (65.2 %) belonged 
to urban areas. Monthly family income up to Rs. 25000 was noted in 188 (51.5%) and 177 (48.5%) had monthly 
family income rupees more than 25000. History of smoking was present in 89 (24.4%) of our study cases. Mean 
body mass index of our study cases was 26.32 ± 2.45 kg/m
2 
and obesity was present in 112 (30.7 %) of our 
study cases. Mean disease duration was 12.35 ± 7.52 years and 239 (65.5%) had duration of illness more than 5 
years.   
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Of these 365 study cases, 238 (65.2 %) were illiterate and 127 (34.8 %) were literate. Controlled diabetes was 
noted in 75 (20.5%) and 75 (20.5%) were taking proper treatment while none of them had undergone regular 
eye checkup. Diabetic retinopathy was 151 (41.4%) of our study cases.  
 
DISCUSSION;  
In the year 2000, there were around 171 million people with diabetes globally, and by 2030, it is estimated that 
this number would increase to 366 million. As the number of persons with diabetes increases, the development 
of microvascular complications like retinopathy, nephropathy and neuropathy also rises. These microvascular 
complications are linked to the duration of diabetes mellitus, poor glycemic control and systolic hypertension. 
The magnitude of damage caused by these microvascular complications of diabetes stresses the need for 
sensitive markers of screening for retinopathy and nephropathy 14-16.  
Our study comprised of a total of 365 patients meeting inclusion criteria of our study. Of these 365 study cases, 
226 (61.9 %) were male patients while 139 (38.1 %) were female patients. A study conducted in India by 
Thakkar et al 
17
 reported 57 % male patients predominance, these findings are similar to that of our study results. 
Saleem et al 18 reported male gender predominance over female patients i.e. 54.14 % male patients, these 
findings are similar to that of our study results. Rani et al 14 reported 52.2 % male patients which is same as that 
of our study results.  
Mean age of our study cases was 50.92 ± 5.77 years (with minimum age of our study cases was 40 years while 
maximum age was 60 years). Mean age of the male patients was noted to be 51.49 ± 5.20 years while that female 
patients was 50.00 ± 6.38 years (p=0.016). Our study results have indicated that majority of our study cases i.e. 
190 (52.1 %) were aged more than 50 years. Rani et al 
14
 reported 58.6 ± 9.6 mean age, these findings are close 
to that of our study results. Nisar et al 
19
 reported 52.18 ± 8.99 years which is similar to that of our study results. 
Jamil et al 20 reported 50.95 ± 10.12 years mean age, these findings are also in compliance with that of ours. 
Thakkar et al 17 61.91 ± 9.16 which is quite higher than our study results, the reason for this disparity is that we 
only included patients ranging from 40-60 years of age. Similar results have been reported by Jamil et al
20
.   
  Of these 365 study cases, 127 (34.8 %) belonged to rural areas and 238 (65.2 %) belonged to 
urban areas. Monthly family income up to Rs. 25000 was noted in 188 (51.5%) and 177 (48.5%) had monthly 
family income rupees more than 25000. History of smoking was present in 89 (24.4%) of our study cases. Mean 
body mass index of our study cases was 26.32 ± 2.45 kg/m
2 
and obesity was present in 112 (30.7 %) of our study 
cases. Of these 365 study cases, 238 (65.2 %) were illiterate and 127 (34.8 %) were literate.   
Mean disease duration was 12.35 ± 7.52 years and 239 (65.5%) had duration of illness more than 5 
years.  Crimi et al 
21
 reported 14.7 ± 7.1 years mean duration of diabetes in diabetic retinopathy, these results are 
close to that of our study results. Rani et al 
85
 6.6 years mean disease duration among targeted population. These 
findings are quite lower than that of our study results. 
Controlled diabetes was noted in 75 (20.5%) and 75 (20.5%) were taking proper treatment while none of them 
had undergone regular eye checkup.  Similar results have by reported  by Rani et al 14 and Thakkar et al 17.  
 
Diabetic retinopathy was 151 (41.4%) of our study cases. A study from Jordan conducted by Al-Amer et al 
13
 
reported 38.7 % diabetic retinopathy in diabetic patients having hypertension which is close to our study results. 
A study conducted by Rehman et al 
22 
reported 58 % diabetic retinopathy among hypertensive patients which is 
close to our study results.  
 
CONCLUSION; 
Very high frequency of diabetic retinopathy was noted in patients with diabetes and hypertension in our study. 
Diabetic retinopathy was significantly associated with residential status, increasing age, monthly family income, 
smoking, treatment status, disease duration and obesity. Diabetic retinopathy was not associated with control of 
diabetes and hypertension. All clinicians treating such patients must educate their patients regarding regular eye 
check up to decrease disease morbidity.   
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